rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    MNPR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      BTIG reiterates Monopar Therapeutics stock rating on NDA progress
      Nov 12Investing.comMNPR
      H.C. Wainwright reiterates Buy rating on Monopar stock at $125
      Nov 12Investing.comMNPR
      Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
      Nov 12Yahoo FinanceMNPR
      Monopar presents Wilson disease trial data at liver conference
      Nov 9Investing.comMNPR
      Monopar Presents Data Highlighting Residual Disease Burden in Treatment-Experienced Wilson Disease Patients and Long-Term Molybdenum Safety Data for ALXN1840 at AASLD – The Liver Meeting® 2026
      Nov 9Yahoo FinanceMNPR
      Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data
      Nov 2Yahoo FinanceMNPR
      Monopar Therapeutics director Christopher Starr sells shares worth $659k
      Oct 12Investing.comMNPR
      Monopar Therapeutics director Starr sells $659,386 in stock
      Oct 6Investing.comMNPR
      Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing
      Oct 5Yahoo FinanceMNPR
      Monopar Therapeutics CEO Robinson sells $2.5m in stock
      Sep 29Investing.comMNPR
      H.C. Wainwright Reaffirms Their Buy Rating on Monopar Therapeutics Inc (MNPR)

      Detailed price information for Monopar Therapeutics Inc (MNPR-Q) from The Globe and Mail including charting and trades.

      Sep 23The Globe and MailMNPR
      Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Monopar Therapeutics Inc (MNPR)

      Detailed price information for Monopar Therapeutics Inc (MNPR-Q) from The Globe and Mail including charting and trades.

      Sep 12The Globe and MailMNPR
      Monopar Therapeutics director Kim Tsuchimoto sells $455,566 in shares
      Aug 29Investing.comMNPR
      Monopar Therapeutics director Raymond Anderson sells $351,835 in stock
      Aug 29Investing.comMNPR
      Monopar Therapeutics director Raymond Anderson sells $351k in stock
      Aug 28Investing.comMNPR
      Monopar director Kim Tsuchimoto sells $455k in common stock
      Aug 28Investing.comMNPR
      Monopar Therapeutics acting CMO sells $111 of stock, exercises options
      Aug 28Investing.comMNPR

      This is the newest page. Registered accounts read further back.